Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma Metabolite Profiles of Alzheimer’s Disease and Mild Cognitive Impairment
Gang Wang, Yi Zhou, Fengjie Huang, et al.
Journal of Proteome Research (2014) Vol. 13, Iss. 5, pp. 2649-2658
Closed Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Blood-based molecular biomarkers for Alzheimer’s disease
Henrik Zetterberg, Samantha Burnham
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 226
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
Kwangsik Nho, Alexandra Kueider‐Paisley, Shahzad Ahmad, et al.
JAMA Network Open (2019) Vol. 2, Iss. 7, pp. e197978-e197978
Open Access | Times Cited: 184
Metabolomics for the masses: The future of metabolomics in a personalized world
Drupad K. Trivedi, Katherine A. Hollywood, Royston Goodacre
European Journal of Molecular & Clinical Medicine (2017) Vol. 3, Iss. 6, pp. 294-294
Open Access | Times Cited: 174
Microbiota from Alzheimer’s patients induce deficits in cognition and hippocampal neurogenesis
Stefanie Grabrucker, Moira Marizzoni, Edina Silajdžić, et al.
Brain (2023) Vol. 146, Iss. 12, pp. 4916-4934
Open Access | Times Cited: 108
Explainable AI for clinical and remote health applications: a survey on tabular and time series data
Flavio Di Martino, Franca Delmastro
Artificial Intelligence Review (2022) Vol. 56, Iss. 6, pp. 5261-5315
Open Access | Times Cited: 85
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 75
Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
Burak Yuluğ, Özlem Altay, Xiangyu Li, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Amino Acid Catabolism in Alzheimer’s Disease Brain: Friend or Foe?
Jeddidiah W. D. Griffin, Patrick C. Bradshaw
Oxidative Medicine and Cellular Longevity (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 153
Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy
Robert A. Stern, Yorghos Tripodis, Christine M. Baugh, et al.
Journal of Alzheimer s Disease (2016) Vol. 51, Iss. 4, pp. 1099-1109
Open Access | Times Cited: 151
A multiomics approach to heterogeneity in Alzheimer’s disease: focused review and roadmap
AmanPreet Badhwar, G. Peggy McFall, Shraddha Sapkota, et al.
Brain (2019) Vol. 143, Iss. 5, pp. 1315-1331
Open Access | Times Cited: 129
Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis
Medi Kori, Büşra Aydın, Semra Ünal, et al.
OMICS A Journal of Integrative Biology (2016) Vol. 20, Iss. 11, pp. 645-661
Closed Access | Times Cited: 128
Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis–mass spectrometry
Raúl González‐Domínguez, Antonia Garcı́a, Tamara García‐Barrera, et al.
Electrophoresis (2014) Vol. 35, Iss. 23, pp. 3321-3330
Closed Access | Times Cited: 115
Lower brain and blood nutrient status in Alzheimer's disease: Results from meta‐analyses
Martijn C. de Wilde, Bruno Vellas, Elodie M. Girault, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2017) Vol. 3, Iss. 3, pp. 416-431
Open Access | Times Cited: 115
Repetitive head impact exposure and later‐life plasma total tau in former National Football League players
Michael L. Alosco, Yorghos Tripodis, Johnny Jarnagin, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2016) Vol. 7, Iss. 1, pp. 33-40
Open Access | Times Cited: 94
Precision pharmacology for Alzheimer’s disease
Harald Hampel, Andrea Vergallo, Lisi Flores Aguilar, et al.
Pharmacological Research (2018) Vol. 130, pp. 331-365
Open Access | Times Cited: 90
Metabolomics in the Development and Progression of Dementia: A Systematic Review
Yanfeng Jiang, Zhen Zhu, Jie Shi, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 77
Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment
Nishit Pathak, Sunil Kumar Vimal, Ishi Tandon, et al.
Metabolic Brain Disease (2021) Vol. 37, Iss. 1, pp. 67-104
Closed Access | Times Cited: 62
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Zdeněk Fišar
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1676-1676
Open Access | Times Cited: 52
Intermittent fasting protects against Alzheimer’s disease in mice by altering metabolism through remodeling of the gut microbiota
Rui‐Yuan Pan, Jing Zhang, Jinlei Wang, et al.
Nature Aging (2022) Vol. 2, Iss. 11, pp. 1024-1039
Closed Access | Times Cited: 46
Metabolic phenotyping reveals an emerging role of ammonia abnormality in Alzheimer’s disease
Tianlu Chen, Fengfeng Pan, Qi Huang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Using direct infusion mass spectrometry for serum metabolomics in Alzheimer’s disease
Raúl González‐Domínguez, Tamara García‐Barrera, José Luis Gómez‐Ariza
Analytical and Bioanalytical Chemistry (2014) Vol. 406, Iss. 28, pp. 7137-7148
Closed Access | Times Cited: 90
Proteomics and metabolomics in ageing research: from biomarkers to systems biology
Jessica M. Hoffman, Yang Lyu, Scott D. Pletcher, et al.
Essays in Biochemistry (2017) Vol. 61, Iss. 3, pp. 379-388
Open Access | Times Cited: 86
Metabolomics-based screening of salivary biomarkers for early diagnosis of Alzheimer's disease
Qun Liang, Han Liu, Tianyu Zhang, et al.
RSC Advances (2015) Vol. 5, Iss. 116, pp. 96074-96079
Closed Access | Times Cited: 83
NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls
João Figueira, Pär Jonsson, Annelie Nordin Adolfsson, et al.
Molecular BioSystems (2016) Vol. 12, Iss. 8, pp. 2562-2571
Closed Access | Times Cited: 81
Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer’s Disease
Tao Huan, Tran Tran, Jiamin Zheng, et al.
Journal of Alzheimer s Disease (2018) Vol. 65, Iss. 4, pp. 1401-1416
Closed Access | Times Cited: 76
Page 1 - Next Page

Scroll to top